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CONDUCTOMETRIC DETERMINATION OF THE TWO ANGIOTENSIN-CONVERTING ENZYME 
INHIBITORS, RAMIPRIL AND ENALAPRIL MALEATE IN PURE FORM AND IN TABLETS USING 
PHOSPHOTUNGSTIC ACID
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Simple and sensitive conductometric method has been developed for the determination of ramipril and enalapril maleate using phosphotungstic 
acid (PTA) in pure form and in tablets. The proposed method is based on the conductometric determination of 5–20 mg and 7–20 mg of ramipril and 
enalapril maleate by titration with PTA in aqueous solution. All the reaction conditions for the proposed methods have been studied. The proposed 
methods were applied successfully for the determination of ramipril and enalapril maleate in tablets; the relative standard deviation values were 
not exceeding two for both drugs. The results obtained were compared statistically with those obtained by the reference method and showed no 
significant differences regarding accuracy and precision.
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INTRODUCTION
Ramipril is (2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(ethoxycarbonyl)-3- phenylpropyl]
amino]propanoyl]octahydrocyclopenta[b]pyrrole-2- carboxylic acid [1], 
chemical structure is shown in Fig. 1. It is an angiotensin-converting 
enzyme (ACE) inhibitor used in the treatment of hypertension, heart 
failure, and after myocardial infarction to improve survival in patients 
with clinical evidence of heart failure [2].
Many methods have been described for the determination of 
ramipril. Concerning the chromatographic methods, it has been 
determined in pharmaceutical preparations or biological fluids either 
alone or combination with other drugs by high-performance liquid 
chromatography (HPLC) [4-7]. Furthermore, HPTLC methods have 
been reported [8,9].
Literature described different spectroscopic methods for determination 
of ramipril including spectrophotometric methods [10-17], and also 
derivative spectrophotometric methods [18,19], and chemometric 
methods [20] have been reported.
Other reported techniques were voltammetry [21,22], 
potentiometry [23], conductometry [24], and capillary electrophoresis 
methods [25] have been applied for the determination of ramipril.
Enalapril maleate is ((S)-1-{N-[1-(ethoxy carbonyl)-3-phenylpropyl]-L-
alanyl}-L-proline, (Z)-2-butenedioate), chemical structure is shown in 
Fig. 2. It is a prodrug that is hydrolyzed in the body to enalapril at which 
is an inhibitor of ACE.
The USP 24 describes HPLC method for its quantitative estimation [3]. 
Quantitative determination of enalapril maleate can be carried out 
by various reported methods such as HPLC [26-30], capillary zone 
electrophoresis method [31], polarography [32], atomic absorption 
spectroscopy [12], and membrane selective electrodes [33]. Some 
spectrophotometric methods have also been reported for quantitative 
estimation of enalapril maleate in bulk and dosage forms [12,34-39]. 
Different spectrophotometric method [40] has also been reported.
Precipitimetry conductometric titrations using phosphotungstic acid 
(PTA) as titrant are commonly used for the quantitative determination 
of different compounds, e.g. reproterol HCl, pipazethate HCl, salbutamol 
sulfate [41], papaverine hydrochloride [42], and dextromethorphan [43].
Phosphotungstic acid was also used in the spectrophotometric 
estimation of mebikar [44].
In this study, a simple and accurate conductometric method has been 
proposed for determining ramipril and enalapril maleate, based on the 
conductometric titration with PTA. The proposed methods have been 
applied to the assay of ramipril and enalapril maleate in tablets.
METHODS
Materials and reagents
•	 All	 solvents	 and	 reagents	were	of	 analytical	 grade,	 and	double	
distilled water was used throughout the work.
•	 Ramipril	and	enalapril	maleate	(Egyptian	group	for	pharmaceutical	
industries Co., El-Obour city, Egypt).
•	 PTA	(scientific	limited,	Northampton,	UK)
Pharmaceutical preparation
•	 Tritace	protect	 tablets	 (Sanofi-aventis	Egypt	 s.a.e.,	 El	 Sawah	El	
Amiriya, Egypt) labeled to contain 10 mg ramipril per tablet.
•	 Enalapril	maleate	 tablets (October Pharma S.A.E, 6 October City, 
Egypt) labeled to contain 20 mg enalapril maleate per tablet.
Instrumentation
•	 JENWAY	model	 470	 conductivity/TDS	meter	 (470	 201),	with	
Conductivity/temperature	probe	(027	298)	was	used.
General procedures
Preparation of stock and standard working solutions
1) Ramipril
Working	standard	solution	of	1	mg/ml	(2.4×10−3 M) was prepared by 
dissolving 100 mg of the pure drug in the least amount of methanol 
then completing to 100 ml with double distilled water.
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Enalapril maleate
Working	standard	solution	of	1	mg/ml	(2.03×10−3 M) was prepared by 
dissolving 100 mg of the pure drug in 100 ml double distilled water.
PTA acid
Working	solution	1×10−3 M prepared by dissolving 0.288 g in double 
distilled water then completing to 100 ml with double distilled water.
Construction of calibration curves
Aliquots of sample solution containing 5–20 mg and 7–20 mg of 
ramipril and enalapril maleate respectively were transferred to a 50 ml 
calibrated flask; volume was made up to the mark using double distilled 
water. The contents of the calibrated flask were transferred to a beaker, 
and the conductivity cell was immersed.
PTA was used as titrant; the conductance was measured subsequent 
to each reagent solution addition, and after stirring for 2 min, the 
conductance was corrected for dilution [45] by means of the following 
equation, assuming that conductivity is a linear function of dilution.
A graph of corrected conductivity versus the volume of added titrant 
was constructed, and end-point was determined conductometrically.




concentration of titrant, and N is no of moles of titrant consumed by 
one mole of drug.
Determination of stoichiometric balance using Job’s method [46]
6 mL of 10−3M ramipril and enalapril maleate were transferred to 50 
mL volumetric flasks, and the volumes were made up to the mark with 
double distilled water. The contents were transferred to a beaker, and 
the conductivity cell was immersed.
10−3 M PTA was used for titration. The conductance was measured 
subsequent to each reagent solution addition and after thorough stirring 
for 2 min. A graph of conductivity versus volume was constructed.
Curve break is observed at drug-reagent molar ratio of 3:1.
Procedure for tablets
The contents of 10 tablets were pulverized, an accurately weighed 
amount equivalent to 100 mg of the studied drugs were extracted by 
shaking with 50 ml double distilled water for enalapril maleate while 
for ramipril, it was extracted with, least amount of methanol then these 
contents were transferred to a 100 ml volumetric flask, completed to 
the mark using double distilled water then filtered.
RESULTS AND DISCUSSION
On using PTA as a titrant for the determination of ramipril and enalapril 
maleate, ion associate is formed leading to a regular rise in conductance 
up to the equivalence point where a sudden change in the slope occurs.
Representative titration curve is shown in Figs. 3 and 4. Two straight 
lines are obtained, intersecting at the end-point. The conductance 
measured before the addition of the titrant (volume of PTA equals zero) 
is mainly due to the presence of ramipril and enalapril maleate. On 
adding PTA, an ion associate is formed between both drugs and PTA 
and the conductivity increases [47]. After the endpoint, more reagent 
acid is added, and the conductivity increases more rapidly. The reaction 
may be represented by the following equations:
3 Ramipril + [PTA]−3→[Ramipril]+3 [PTA]−3
3 Enalapril maleate+[PTA]−3→[Enalapril	maleate]+3 [PTA]−3
The results from the conductometic titrations are summarized in 
Table 1. The data show that accurate results were obtained with good 
recoveries and low standard deviation (SD) values. The optimum 
concentration ranges for determination of the cited drug were in 
the range of 5–20 mg and 7–20 for ramipril and enalapril maleate, 
respectively. At such ranges, sharp inflections and stable conductance 
reading were obtained.
Investigations were carried out to establish the most favorable 
conditions for the reaction to attain endpoint. The influence of some 
variables on the reaction has been tested, and the optimum conditions 
for performing the titration in a quantitative manner were elucidated 
as described below.
Fig. 1: Chemical structure of ramipril
Fig. 2: Chemical structure of enalapril maleate
Fig. 3: Conductometric titration of 10 mg of ramipril using 1×10−3 
M phosphotungstic acid
Fig. 4: Conductometric titration of 20 mg of enalapril maleate 
using 1×10−3 M phosphotungstic acid
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Titrations in different media were attempted to obtain the best 
results. Preliminary experiments in
1. Aqueous solutions of both drug and reagent,
2.	 Drug	and	reagent	solutions	in	ethanol-water	(50%,	v/v)	mixture,
3. Methanolic solutions of both drug and reagent,
4.	 Drug	and	reagent	solutions	in	methanol-water	(50%	v/v)	mixture,
5.	 Drug	and	reagent	solution	in	acetone-water	(50%	v/v)	mixture.
Preliminary experiments showed that procedure in aqueous media 
was the most suitable for successful results for the cited drug (higher 
conductance and most sharp endpoint.).
Reagent’s concentration
The optimum concentration of PTA was 10−3 M to achieve a constant and 
highly stable conductance reading after 2 min mixing. Concentrations 
less than these gave unstable readings and more time was needed to 
obtain constant conductance values.
Method validation
The developed methods were validated according to ICH guidelines [48]. 
The linearity range of conductivity as a function of drug concentration 
(Tables 1 and 2) provides an accurate measure of sensitivity of reagents 
used. Calibration curves have determination coefficients (R2) higher 
than 0.999 indicating good linearity. According to ICH guidelines, the 
obtained values indicated a high sensitivity of the proposed methods. 
Statistical comparison of the results obtained from the analysis of the 
studied drug by the proposed method to those of reference method [1] 
using t- and F-tests, showed no significant difference between them 
(Table 3). Accuracy of the methods was expressed as the mean recovery 
percentage (average of four replicates within Beer’s law limits) while 
the precision was expressed as the relative SD percentage (Table 4).
CONCLUSION
The simple and rapid procedure described in this chapter can be an 
alternative to the more complex and expensive methods for assay of 
Table 1: Conductometric determination of ramipril and enalapril maleate in their pure forms using 1×10−3M PTA
Ramipril Enalapril maleate
Taken (mg) Found %* Taken (mg) Found %*
5 100.00 7 101.26
7 98.21 10 100.47
10 100.00 12 99.73
12 99.96 15 98.52
15 98.33 17 100.87






SD: Standard deviation, RSD: Relative standard deviation, SE: Standard error, PTA: Phosphotungstic acid
Table 2: Conductometric determination of ramipril and enalapril maleate in their tablets dosage forms using 1×10−3 M PTA
Ramipril Enalapril maleate
Tritace protect tablet Enalapril maleate tablet
Conc (mg) Recovery %* Conc. (mg) Recovery %*
5 100.00 10 100.44
7 99.10 12 99.75
15 99.96 15 99.01
17 100.42 17 99.13






SD: Standard deviation, RSD: Relative standard deviation, SE: Standard error, PTA: Phosphotungstic acid
Table 3: Statistical analysis of results obtained by the proposed method, applied on Tritace® protect tablets compared with the reference 
method
Parameters Ramipril Enalapril maleate
Reference method [1] Proposed method Reported method [39] Proposed method
N 3 5 6 5
Mean recovery 101.00 100.14 100.215 99.76
Variance 1.08 0.614 1.807 0.481
±SD 1.04 0.78 1.344 0.694
±RSD 1.03 0.78 1.347 0.692
±SE 0.60 0.32 0.549 0.310
Student-t [49] 1.346 (2.447) 0.681 (2.262)a
F-test [49] 1.77 (2.417) 3.756 (5.19)b
a and b are the theoretical student t-values and F-ratios at P 0.05. SD: Standard deviation, RSD: Relative standard deviation, SE: Standard error
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ramipril and enalapril maleate. The proposed method is easy and very 
useful for the determination of the studied drugs in pharmaceutical 
formulations and can be applied in laboratories for routine analysis.
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